Profiel
David Banks joined CV Therapeutics, Inc. in 2007 as Senior Vice President of Operations.
Previously, he was Vice President of Consumer Alliance Management of Johnson & Johnson and Vice President of Manufacturing.
Mr. Banks was Vice President of Manufacturing of ALZA Corporation from 1995 to 2001 and worked for Syntex.
He received an MBA from East Tennessee State University and a BS in Industrial Engineering from Tennessee Tech University.
Eerdere bekende functies van David Banks
| Bedrijven | Functie | Einde |
|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Operationeel Directeur | 02-05-2011 |
| ALZA CORPORATION | Corporate Officer/Principal | 01-01-2001 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Opleiding van David Banks
| East Tennessee State University | Masters Business Admin |
| Tennessee Technological University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
